Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
1 clinical trials · Condition
◉ Watch Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4
| Record | Firm | Date |
|---|---|---|
| Temozolomide and Procarbazine With Cilengitide for Patients With Glioblastoma Multiforme Without Methylation of the MGMT Promoter Gene (NCT01124240) | Northern Sydney and Central Coast Area Health Service | 2009-11-01 |
Track Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4 automatically
Every clearance here is in the API, with alerts when new ones post.